You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RAPP Sale Disclosure
Ceesay Abraham · SEC Form 4 · Filed Sep 9, 2026
Sale
Calculated transaction value
$325.31K
Ceesay Abraham Chief Executive Officer
RAPP
Rapport Therapeutics
RAPP
Transaction date
Sep 8, 2026
Public filing date
Sep 9, 2026
Filing lag
Filed 1 day later
RAPP daily price context
Close on/before transaction
$46.09
Sep 8, 2026
First close after public filing
$43.46
Sep 10, 2026
30-day return after filing
-29.48%
Through Oct 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 7,141 shares @ $45.55
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-386436
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$374.5K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Rapport Therapeutics, Inc. RAPP Current | Sale | Sep 8, 2026 | $325.31K |
| Rapport Therapeutics, Inc. RAPP | Sale | Sep 8, 2026 | $49.19K |